Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2000 Oct;55(Suppl 2):S3–S9. doi: 10.1136/thorax.55.suppl_2.S3

Aspirin and other anti-inflammatory drugs

S J Vane
PMCID: PMC1765977  PMID: 10992545

Full Text

The Full Text of this article is available as a PDF (146.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barner A. Review of clinical trials and benefit/risk ratio of meloxicam. Scand J Rheumatol Suppl. 1996;102:29–37. doi: 10.3109/03009749609097228. [DOI] [PubMed] [Google Scholar]
  2. Beiche F., Scheuerer S., Brune K., Geisslinger G., Goppelt-Struebe M. Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett. 1996 Jul 22;390(2):165–169. doi: 10.1016/0014-5793(96)00604-7. [DOI] [PubMed] [Google Scholar]
  3. Breitner J. C. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu Rev Med. 1996;47:401–411. doi: 10.1146/annurev.med.47.1.401. [DOI] [PubMed] [Google Scholar]
  4. Cao C., Matsumura K., Yamagata K., Watanabe Y. Cyclooxygenase-2 is induced in brain blood vessels during fever evoked by peripheral or central administration of tumor necrosis factor. Brain Res Mol Brain Res. 1998 May;56(1-2):45–56. doi: 10.1016/s0169-328x(98)00025-4. [DOI] [PubMed] [Google Scholar]
  5. Catella-Lawson F., McAdam B., Morrison B. W., Kapoor S., Kujubu D., Antes L., Lasseter K. C., Quan H., Gertz B. J., FitzGerald G. A. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther. 1999 May;289(2):735–741. [PubMed] [Google Scholar]
  6. Cummings D. M., Amadio P., Jr A review of selected newer nonsteroidal anti-inflammatory drugs. Am Fam Physician. 1994 Apr;49(5):1197–1202. [PubMed] [Google Scholar]
  7. Dequeker J., Hawkey C., Kahan A., Steinbrück K., Alegre C., Baumelou E., Bégaud B., Isomäki H., Littlejohn G., Mau J. Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis. Br J Rheumatol. 1998 Sep;37(9):946–951. doi: 10.1093/rheumatology/37.9.946. [DOI] [PubMed] [Google Scholar]
  8. Dinchuk J. E., Car B. D., Focht R. J., Johnston J. J., Jaffee B. D., Covington M. B., Contel N. R., Eng V. M., Collins R. J., Czerniak P. M. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature. 1995 Nov 23;378(6555):406–409. doi: 10.1038/378406a0. [DOI] [PubMed] [Google Scholar]
  9. Distel M., Mueller C., Bluhmki E., Fries J. Safety of meloxicam: a global analysis of clinical trials. Br J Rheumatol. 1996 Apr;35 (Suppl 1):68–77. doi: 10.1093/rheumatology/35.suppl_1.68. [DOI] [PubMed] [Google Scholar]
  10. Eberhart C. E., Coffey R. J., Radhika A., Giardiello F. M., Ferrenbach S., DuBois R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994 Oct;107(4):1183–1188. doi: 10.1016/0016-5085(94)90246-1. [DOI] [PubMed] [Google Scholar]
  11. Ehrich E. W., Dallob A., De Lepeleire I., Van Hecken A., Riendeau D., Yuan W., Porras A., Wittreich J., Seibold J. R., De Schepper P. Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model. Clin Pharmacol Ther. 1999 Mar;65(3):336–347. doi: 10.1016/S0009-9236(99)70113-X. [DOI] [PubMed] [Google Scholar]
  12. Ferreira S. H., Moncada S., Vane J. R. Indomethacin and aspirin abolish prostaglandin release from the spleen. Nat New Biol. 1971 Jun 23;231(25):237–239. doi: 10.1038/newbio231237a0. [DOI] [PubMed] [Google Scholar]
  13. Fries J. Toward an understanding of NSAID-related adverse events: the contribution of longitudinal data. Scand J Rheumatol Suppl. 1996;102:3–8. doi: 10.3109/03009749609097225. [DOI] [PubMed] [Google Scholar]
  14. Fu J. Y., Masferrer J. L., Seibert K., Raz A., Needleman P. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem. 1990 Oct 5;265(28):16737–16740. [PubMed] [Google Scholar]
  15. García Rodríguez L. A., Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994 Mar 26;343(8900):769–772. doi: 10.1016/s0140-6736(94)91843-0. [DOI] [PubMed] [Google Scholar]
  16. Gibb W., Sun M. Localization of prostaglandin H synthase type 2 protein and mRNA in term human fetal membranes and decidua. J Endocrinol. 1996 Sep;150(3):497–503. doi: 10.1677/joe.0.1500497. [DOI] [PubMed] [Google Scholar]
  17. Gilroy D. W., Colville-Nash P. R., Willis D., Chivers J., Paul-Clark M. J., Willoughby D. A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med. 1999 Jun;5(6):698–701. doi: 10.1038/9550. [DOI] [PubMed] [Google Scholar]
  18. Giuliano F., Warner T. D. Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs. Br J Pharmacol. 1999 Apr;126(8):1824–1830. doi: 10.1038/sj.bjp.0702518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gustafson-Svärd C., Lilja I., Hallbök O., Sjödahl R. Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats. Gut. 1996 Jan;38(1):79–84. doi: 10.1136/gut.38.1.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Harada Y., Hatanaka K., Kawamura M., Saito M., Ogino M., Majima M., Ohno T., Ogino K., Yamamoto K., Taketani Y. Role of prostaglandin H synthase-2 in prostaglandin E2 formation in rat carrageenin-induced pleurisy. Prostaglandins. 1996 Jan;51(1):19–33. doi: 10.1016/0090-6980(95)00168-9. [DOI] [PubMed] [Google Scholar]
  21. Harris R. C., McKanna J. A., Akai Y., Jacobson H. R., Dubois R. N., Breyer M. D. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest. 1994 Dec;94(6):2504–2510. doi: 10.1172/JCI117620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Harris R. C. The macula densa: recent developments. J Hypertens. 1996 Jul;14(7):815–822. doi: 10.1097/00004872-199607000-00003. [DOI] [PubMed] [Google Scholar]
  23. Hawkey C., Kahan A., Steinbrück K., Alegre C., Baumelou E., Bégaud B., Dequeker J., Isomäki H., Littlejohn G., Mau J. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment. Br J Rheumatol. 1998 Sep;37(9):937–945. doi: 10.1093/rheumatology/37.9.937. [DOI] [PubMed] [Google Scholar]
  24. Holgate S. T. The pathophysiology of bronchial asthma and targets for its drug treatment. Agents Actions. 1986 Jun;18(3-4):281–287. doi: 10.1007/BF01964985. [DOI] [PubMed] [Google Scholar]
  25. Kargman S., Charleson S., Cartwright M., Frank J., Riendeau D., Mancini J., Evans J., O'Neill G. Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology. 1996 Aug;111(2):445–454. doi: 10.1053/gast.1996.v111.pm8690211. [DOI] [PubMed] [Google Scholar]
  26. Kawamori T., Rao C. V., Seibert K., Reddy B. S. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res. 1998 Feb 1;58(3):409–412. [PubMed] [Google Scholar]
  27. Kirtikara K., Morham S. G., Raghow R., Laulederkind S. J., Kanekura T., Goorha S., Ballou L. R. Compensatory prostaglandin E2 biosynthesis in cyclooxygenase 1 or 2 null cells. J Exp Med. 1998 Feb 16;187(4):517–523. doi: 10.1084/jem.187.4.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kujubu D. A., Fletcher B. S., Varnum B. C., Lim R. W., Herschman H. R. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem. 1991 Jul 15;266(20):12866–12872. [PubMed] [Google Scholar]
  29. Kutchera W., Jones D. A., Matsunami N., Groden J., McIntyre T. M., Zimmerman G. A., White R. L., Prescott S. M. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc Natl Acad Sci U S A. 1996 May 14;93(10):4816–4820. doi: 10.1073/pnas.93.10.4816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Laine L., Sloane R., Ferretti M., Cominelli F. A randomized double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production. Gastrointest Endosc. 1995 Nov;42(5):428–433. doi: 10.1016/s0016-5107(95)70045-5. [DOI] [PubMed] [Google Scholar]
  31. Langenbach R., Morham S. G., Tiano H. F., Loftin C. D., Ghanayem B. I., Chulada P. C., Mahler J. F., Lee C. A., Goulding E. H., Kluckman K. D. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell. 1995 Nov 3;83(3):483–492. doi: 10.1016/0092-8674(95)90126-4. [DOI] [PubMed] [Google Scholar]
  32. Li S., Wang Y., Matsumura K., Ballou L. R., Morham S. G., Blatteis C. M. The febrile response to lipopolysaccharide is blocked in cyclooxygenase-2(-/-), but not in cyclooxygenase-1(-/-) mice. Brain Res. 1999 Apr 17;825(1-2):86–94. doi: 10.1016/s0006-8993(99)01225-1. [DOI] [PubMed] [Google Scholar]
  33. Luk G. D. Prevention of gastrointestinal cancer--the potential role of NSAIDs in colorectal cancer. Schweiz Med Wochenschr. 1996 May 11;126(19):801–812. [PubMed] [Google Scholar]
  34. Luong C., Miller A., Barnett J., Chow J., Ramesha C., Browner M. F. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nat Struct Biol. 1996 Nov;3(11):927–933. doi: 10.1038/nsb1196-927. [DOI] [PubMed] [Google Scholar]
  35. Marcheselli V. L., Bazan N. G. Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus. Inhibition by a platelet-activating factor antagonist. J Biol Chem. 1996 Oct 4;271(40):24794–24799. doi: 10.1074/jbc.271.40.24794. [DOI] [PubMed] [Google Scholar]
  36. Masferrer J. L., Zweifel B. S., Seibert K., Needleman P. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest. 1990 Oct;86(4):1375–1379. doi: 10.1172/JCI114850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. McAdam B. F., Catella-Lawson F., Mardini I. A., Kapoor S., Lawson J. A., FitzGerald G. A. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):272–277. doi: 10.1073/pnas.96.1.272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. McGeer P. L., McGeer E. G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev. 1995 Sep;21(2):195–218. doi: 10.1016/0165-0173(95)00011-9. [DOI] [PubMed] [Google Scholar]
  39. Meade E. A., Smith W. L., DeWitt D. L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem. 1993 Mar 25;268(9):6610–6614. [PubMed] [Google Scholar]
  40. Mitchell J. A., Akarasereenont P., Thiemermann C., Flower R. J., Vane J. R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11693–11697. doi: 10.1073/pnas.90.24.11693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Mitchell J. A., Belvisi M. G., Akarasereenont P., Robbins R. A., Kwon O. J., Croxtall J., Barnes P. J., Vane J. R. Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br J Pharmacol. 1994 Nov;113(3):1008–1014. doi: 10.1111/j.1476-5381.1994.tb17093.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Mizuno H., Sakamoto C., Matsuda K., Wada K., Uchida T., Noguchi H., Akamatsu T., Kasuga M. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology. 1997 Feb;112(2):387–397. doi: 10.1053/gast.1997.v112.pm9024292. [DOI] [PubMed] [Google Scholar]
  43. Moncada S., Gryglewski R., Bunting S., Vane J. R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 1976 Oct 21;263(5579):663–665. doi: 10.1038/263663a0. [DOI] [PubMed] [Google Scholar]
  44. Morham S. G., Langenbach R., Loftin C. D., Tiano H. F., Vouloumanos N., Jennette J. C., Mahler J. F., Kluckman K. D., Ledford A., Lee C. A. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell. 1995 Nov 3;83(3):473–482. doi: 10.1016/0092-8674(95)90125-6. [DOI] [PubMed] [Google Scholar]
  45. Nakatsugi S., Fukutake M., Takahashi M., Fukuda K., Isoi T., Taniguchi Y., Sugimura T., Wakabayashi K. Suppression of intestinal polyp development by nimesulide, a selective cyclooxygenase-2 inhibitor, in Min mice. Jpn J Cancer Res. 1997 Dec;88(12):1117–1120. doi: 10.1111/j.1349-7006.1997.tb00337.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. O'Banion M. K., Sadowski H. B., Winn V., Young D. A. A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem. 1991 Dec 5;266(34):23261–23267. [PubMed] [Google Scholar]
  47. O'Neill G. P., Ford-Hutchinson A. W. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 1993 Sep 13;330(2):156–160. doi: 10.1016/0014-5793(93)80263-t. [DOI] [PubMed] [Google Scholar]
  48. Oshima M., Dinchuk J. E., Kargman S. L., Oshima H., Hancock B., Kwong E., Trzaskos J. M., Evans J. F., Taketo M. M. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 1996 Nov 29;87(5):803–809. doi: 10.1016/s0092-8674(00)81988-1. [DOI] [PubMed] [Google Scholar]
  49. Pasinetti G. M., Aisen P. S. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience. 1998 Nov;87(2):319–324. doi: 10.1016/s0306-4522(98)00218-8. [DOI] [PubMed] [Google Scholar]
  50. Patrignani P., Panara M. R., Greco A., Fusco O., Natoli C., Iacobelli S., Cipollone F., Ganci A., Créminon C., Maclouf J. Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther. 1994 Dec;271(3):1705–1712. [PubMed] [Google Scholar]
  51. Picot D., Loll P. J., Garavito R. M. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature. 1994 Jan 20;367(6460):243–249. doi: 10.1038/367243a0. [DOI] [PubMed] [Google Scholar]
  52. Raz A., Wyche A., Needleman P. Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases. Proc Natl Acad Sci U S A. 1989 Mar;86(5):1657–1661. doi: 10.1073/pnas.86.5.1657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Risbridger G. P. Recent progress in our understanding of inhibin in the prostate gland. J Endocrinol. 1998 Apr;157(1):1–4. doi: 10.1677/joe.0.1570001. [DOI] [PubMed] [Google Scholar]
  54. Rosen G. D., Birkenmeier T. M., Raz A., Holtzman M. J. Identification of a cyclooxygenase-related gene and its potential role in prostaglandin formation. Biochem Biophys Res Commun. 1989 Nov 15;164(3):1358–1365. doi: 10.1016/0006-291x(89)91819-6. [DOI] [PubMed] [Google Scholar]
  55. Roth G. J., Stanford N., Majerus P. W. Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci U S A. 1975 Aug;72(8):3073–3076. doi: 10.1073/pnas.72.8.3073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Samet J. M., Reed W., Ghio A. J., Devlin R. B., Carter J. D., Dailey L. A., Bromberg P. A., Madden M. C. Induction of prostaglandin H synthase 2 in human airway epithelial cells exposed to residual oil fly ash. Toxicol Appl Pharmacol. 1996 Nov;141(1):159–168. doi: 10.1006/taap.1996.0272. [DOI] [PubMed] [Google Scholar]
  57. Sawdy R., Slater D., Fisk N., Edmonds D. K., Bennett P. Use of a cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery. Lancet. 1997 Jul 26;350(9073):265–266. doi: 10.1016/S0140-6736(05)62229-5. [DOI] [PubMed] [Google Scholar]
  58. Schmassmann A., Peskar B. M., Stettler C., Netzer P., Stroff T., Flogerzi B., Halter F. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats. Br J Pharmacol. 1998 Mar;123(5):795–804. doi: 10.1038/sj.bjp.0701672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Schneider A., Stahl R. A. Cyclooxygenase-2 (COX-2) and the kidney: current status and potential perspectives. Nephrol Dial Transplant. 1998 Jan;13(1):10–12. doi: 10.1093/ndt/13.1.10. [DOI] [PubMed] [Google Scholar]
  60. Senna G. E., Passalacqua G., Andri G., Dama A. R., Albano M., Fregonese L., Andri L. Nimesulide in the treatment of patients intolerant of aspirin and other NSAIDs. Drug Saf. 1996 Feb;14(2):94–103. doi: 10.2165/00002018-199614020-00004. [DOI] [PubMed] [Google Scholar]
  61. Sheng H., Shao J., Kirkland S. C., Isakson P., Coffey R. J., Morrow J., Beauchamp R. D., DuBois R. N. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest. 1997 May 1;99(9):2254–2259. doi: 10.1172/JCI119400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Simmons D. L., Levy D. B., Yannoni Y., Erikson R. L. Identification of a phorbol ester-repressible v-src-inducible gene. Proc Natl Acad Sci U S A. 1989 Feb;86(4):1178–1182. doi: 10.1073/pnas.86.4.1178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Sirois J., Richards J. S. Purification and characterization of a novel, distinct isoform of prostaglandin endoperoxide synthase induced by human chorionic gonadotropin in granulosa cells of rat preovulatory follicles. J Biol Chem. 1992 Mar 25;267(9):6382–6388. [PubMed] [Google Scholar]
  64. Slater D., Allport V., Bennett P. Changes in the expression of the type-2 but not the type-1 cyclo-oxygenase enzyme in chorion-decidua with the onset of labour. Br J Obstet Gynaecol. 1998 Jul;105(7):745–748. doi: 10.1111/j.1471-0528.1998.tb10205.x. [DOI] [PubMed] [Google Scholar]
  65. Smith J. B., Willis A. L. Aspirin selectively inhibits prostaglandin production in human platelets. Nat New Biol. 1971 Jun 23;231(25):235–237. doi: 10.1038/newbio231235a0. [DOI] [PubMed] [Google Scholar]
  66. Spaziani E. P., Lantz M. E., Benoit R. R., O'Brien W. F. The induction of cyclooxygenase-2 (COX-2) in intact human amnion tissue by interleukin-4. Prostaglandins. 1996 Mar;51(3):215–223. doi: 10.1016/0090-6980(96)00005-6. [DOI] [PubMed] [Google Scholar]
  67. Stewart W. F., Kawas C., Corrada M., Metter E. J. Risk of Alzheimer's disease and duration of NSAID use. Neurology. 1997 Mar;48(3):626–632. doi: 10.1212/wnl.48.3.626. [DOI] [PubMed] [Google Scholar]
  68. Thun M. J., Namboodiri M. M., Heath C. W., Jr Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 1991 Dec 5;325(23):1593–1596. doi: 10.1056/NEJM199112053252301. [DOI] [PubMed] [Google Scholar]
  69. Tomlinson A., Appleton I., Moore A. R., Gilroy D. W., Willis D., Mitchell J. A., Willoughby D. A. Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy. Br J Pharmacol. 1994 Nov;113(3):693–698. doi: 10.1111/j.1476-5381.1994.tb17048.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Topper J. N., Cai J., Falb D., Gimbrone M. A., Jr Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10417–10422. doi: 10.1073/pnas.93.19.10417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Vane J. R., Bakhle Y. S., Botting R. M. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998;38:97–120. doi: 10.1146/annurev.pharmtox.38.1.97. [DOI] [PubMed] [Google Scholar]
  72. Vane J. R., Botting R. M. Mechanism of action of aspirin-like drugs. Semin Arthritis Rheum. 1997 Jun;26(6 Suppl 1):2–10. doi: 10.1016/s0049-0172(97)80046-7. [DOI] [PubMed] [Google Scholar]
  73. Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]
  74. Walenga R. W., Kester M., Coroneos E., Butcher S., Dwivedi R., Statt C. Constitutive expression of prostaglandin endoperoxide G/H synthetase (PGHS)-2 but not PGHS-1 in hum an tracheal epithelial cells in vitro. Prostaglandins. 1996 Nov;52(5):341–359. doi: 10.1016/s0090-6980(96)00101-3. [DOI] [PubMed] [Google Scholar]
  75. Warner T. D., Giuliano F., Vojnovic I., Bukasa A., Mitchell J. A., Vane J. R. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7563–7568. doi: 10.1073/pnas.96.13.7563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Whittle B. J., Higgs G. A., Eakins K. E., Moncada S., Vane J. R. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature. 1980 Mar 20;284(5753):271–273. doi: 10.1038/284271a0. [DOI] [PubMed] [Google Scholar]
  77. Xie W. L., Chipman J. G., Robertson D. L., Erikson R. L., Simmons D. L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2692–2696. doi: 10.1073/pnas.88.7.2692. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES